Topic: Juul

Former FDA Commissioner Scott Gottlieb discusses the implications of the Supreme Court overturning the Chevron doctrine. He suggests that while fact-based scientific decisions may remain stable, the agency will face increased litigation when attempting to regulate new technologies or flavored tobacco products without explicit Congressional mandates.

The FDA has approved the sale of the first menthol-flavored e-cigarettes, a move that benefits major tobacco companies like Philip Morris. This follows a period where independent vaping companies were driven out of business by high regulatory costs. Critics argue the government is clearing the market of competition to facilitate a taxable nicotine monopoly controlled by established tobacco corporations.

The FDA has reversed its decision on Juul vapes after previously imposing regulations that devastated the independent vaping industry. The hosts argue that the initial crackdown, which required $1 million per flavor for market entry, cleared out competition to benefit large incumbents. They link this regulatory behavior to the need for overturning Chevron deference to prevent agencies from "running roughshod" over specific industries.

Juul Labs agreed to pay $438.5 million to 34 states to settle investigations into its marketing practices toward minors. The settlement is viewed as a way for states to recoup lost revenue from the Master Settlement Agreement (MSA), which relies on tobacco sales. As youth shifted from combustible tobacco to vaping, state budgets tied to tobacco bonds were negatively impacted.

The FDA has temporarily suspended its own ban on Juul electronic cigarettes to conduct further scientific review. This follows a federal appeals court stay of the original order. The discussion notes the rise of IQOS, a non-combustible tobacco product that now holds a significant share of the non-cigarette market internationally.

The FDA is planning to mandate a reduction in nicotine levels for traditional cigarettes and has moved to ban Juul vaping products from the US market. Critics argue this will not reduce smoking but will instead force users to buy more cigarettes to satisfy their addiction, thereby increasing tobacco tax revenue and benefiting Pfizer’s smoking cessation products. The move is characterized as a "big-ass scam" that ignores the failure of past prohibitions.

A tobacco lawyer provided feedback on the "Vape Wars," clarifying the status of Juul's FDA application and the rise of synthetic nicotine as a way for small manufacturers to bypass current regulations. The discussion covers the Master Settlement Agreement and the influence of Big Tobacco on the industry.

Altria is reportedly pivoting toward its new "IQOS" smokeless tobacco device after the systematic dismantling of the e-cigarette and Juul markets. The move is seen as an attempt to maintain tax revenue for states under the Master Settlement Agreement, which traditional vaping threatened. Critics predict the device will fail because it removes the social and sensory element of "blowing smoke" that users enjoy.

The vaping industry faces a coordinated takedown by Big Tobacco and state governments reliant on Master Settlement Agreement funds. As Juul is pushed out of the market, Philip Morris prepares to launch IQOS, a "heat-not-burn" tobacco device. The transition is framed as a way for tobacco companies to reclaim market share lost to independent vape shops and flavored e-liquids.

Following his appearance on the Joe Rogan Experience, one of the hosts has been embraced by the vaping community for explaining the link between faulty THC cartridges containing vitamin E acetate and recent lung illnesses. The discussion touches on the acquisition of Juul and the market entry of IQOS, comparing the industry's struggles to the documentary "Who Killed the Electric Car?"

The U.S. House of Representatives passed a bill that seeks to regulate the vaping industry under the same strict guidelines as traditional tobacco. The legislation includes mandates for "photorealistic" graphic warnings on packaging, which some studies suggest can paradoxically increase product appeal. The bill also targets synthetic nicotine, despite its lack of tobacco-derived components.

At a White House roundtable, Senator Mitt Romney pushed for a ban on flavored vaping products, citing a youth nicotine addiction crisis. The hosts argue that Romney is acting as a shill for Big Tobacco, noting his former firm's ties to the industry. They suggest the crackdown on vaping is designed to protect the market for "heat-not-burn" products like IQOS.

New information regarding the vaping health crisis suggests that "nicotine salts" used by Juul may be a contributing factor. Nicotine salts allow for higher nicotine infusion at lower temperatures, but can become dangerous when used in high-powered "sub-ohm" devices by users seeking a cheaper alternative to Juul pods.

The CDC has identified vitamin E acetate as a "common suspect" in lung injuries linked to vaping after testing 29 samples of lung fluid. The substance is often used as a thickener in black market THC cartridges. The hosts argue that the mainstream media and politicians unfairly targeted the legal nicotine vaping industry (like Juul) to protect tobacco tax revenues.

Anti-vaping campaigns in the United States, largely funded by Michael Bloomberg, are targeting companies like Juul. Critics argue that the push to ban flavored e-cigarettes is a "scam" designed to protect the interests of Big Tobacco and generate new tax revenue through nicotine levies.

Health officials are investigating over 150 cases of severe lung disease linked to vaping, including the first reported death in Illinois. While media reports focus on e-cigarettes, the discussion highlights that many cases involve black-market THC cartridges. The narrative is viewed as a regulatory push to consolidate the market for major tobacco-owned brands like Juul.

Juul Labs CEO Kevin Burns resigned as the company suspended all advertising and lobbying efforts in the U.S. This coincides with Massachusetts Governor Charlie Baker declaring a four-month ban on all vaping products following a spike in lung illnesses. The industry shift occurs as major tobacco companies pivot toward new "heated tobacco" technologies.

Senator Dick Durbin is criticized for making inaccurate claims about nicotine levels in vaping devices. An industry insider suggests that the current regulatory crackdown on vaping benefits "Big Tobacco" companies like Altria and British American Tobacco, who own major vape brands. The source claims the goal is to slow down independent competition while transitioning customers to "heat-not-burn" tobacco products.

The "Vape Wars" involve a push by major industry players like Juul to secure market dominance through FDA regulations that disadvantage smaller competitors. Health concerns regarding lung illnesses are attributed to illicit THC cartridges containing vitamin E acetate rather than standard nicotine e-liquids. The FDA is moving toward banning flavored e-cigarettes, leaving only tobacco-flavored products on the market.

Juul Labs, partially owned by Altria (formerly Philip Morris), is accused of utilizing Big Tobacco's historical playbook to secure market dominance through state-level legislation. The company employs hundreds of lobbyists to push for state laws that preempt local city ordinances, effectively making it harder for independent vape shops to operate. This strategy aims to position Juul as the primary FDA-approved option while eliminating smaller competitors.